Skip to content

Tirzepatide · weekly shot

Mounjaro Dosage Chart: 2.5 mg to 15 mg, Week by Week

Mounjaro starts at 2.5 mg once a week and can rise by 2.5 mg, each step after at least four weeks on the current dose, up to 15 mg. The steps are the same in the US, the UK and the EU. Below the chart: the KwikPen, missed doses, what to do when a dose is hard to tolerate, and why clicks don't count.

Updated · From the Mounjaro prescribing information (revised 8/2026)

Mounjaro dose steps (US and UK prescribing information)

Weekly doseEarliest startRole
2.5 mgWeek 1Starting dose; in the US also an ongoing dose for blood sugar since August 2026
5 mgWeek 5First step up
7.5 mgWeek 9If more is needed
10 mgWeek 13If more is needed; maximum in children
12.5 mgWeek 17If more is needed
15 mgWeek 21Maximum dose in adults

The weeks are the earliest each dose can start, at four weeks per step; they're not a timetable. Many people stay longer on a dose or stop at a lower one. Each dose has its own KwikPen strength.

Source: Mounjaro prescribing information (revised 8/2026)

Turn these steps into dates: the GLP-1 dose calendar

Quick answer

Mounjaro's dose schedule starts at 2.5 mg once a week for at least four weeks. If needed, the dose goes up in 2.5 mg steps (5, 7.5, 10, 12.5 mg), each after at least four weeks on the dose before, to a maximum of 15 mg in adults and 10 mg in children. Your prescriber decides whether and when to step up; you don't have to reach 15 mg.

Log every Mounjaro step in Mingo

Save each shot with its dose and site, get reminded on shot day, and see each dose change marked on your weight chart, next to your side effects, meals and water.

Rated 4.7 out of 5 on the App Store · 1,579 ratings

See how Mingo tracks it: Mounjaro Tracker

How to read the Mounjaro dosage chart

Each row is one weekly dose. Mounjaro always starts at 2.5 mg, and every increase follows one rule: add 2.5 mg, and only after at least four weeks on the dose you’re on (Mounjaro prescribing information; UK patient leaflet). That’s why the earliest anyone could reach 15 mg is week 21.

In practice, the climb is usually slower, and it often stops earlier. Your prescriber may keep you on a dose longer if side effects are bothering you, or stop at a dose that already works. You don’t have to reach 15 mg. Since August 2026 the US label also allows 2.5 mg as an ongoing dose for blood-sugar control, not only as a starting dose. In children 10 and older, the maximum is 10 mg.

What each dose did in the weight-loss trial

In SURMOUNT-1, adults with obesity and without diabetes were assigned one maintenance dose of tirzepatide, the medicine in Mounjaro, and stayed on it (Jastreboff et al., NEJM 2022):

Dose Average weight lost after 72 weeks
5 mg 15.0%
10 mg 19.5%
15 mg 20.9%
Placebo 3.1%

These are averages alongside diet and exercise advice, and individual results vary a lot. They also show why stopping at 5 or 10 mg can be a reasonable choice.

The KwikPen: one pen, one dose, one month

In the UK, Mounjaro comes as a KwikPen, and the US label includes one too. Each pen holds four weekly doses of one strength (UK patient leaflet):

  • One pen lasts a month. Four doses, one a week. When your dose changes, you move to the KwikPen of the new strength, not to more pens.
  • 30 days after first use. An opened KwikPen can be kept at up to 30 °C and is discarded after 30 days, even if a dose is left. Unopened pens go in the refrigerator at 2–8 °C.
  • Don’t use what’s left. The leaflet says not to try to use any medicine left in the pen after the four doses.

About clicks. Online, especially in UK forums, people share click charts to squeeze an extra dose out of a KwikPen or to take a “golden dose” between two strengths. That isn’t in the leaflet, which tells you not to use leftover medicine, and Lilly says splitting tirzepatide doses hasn’t been studied and isn’t recommended (Lilly Medical). If a full step feels like too much, that’s a conversation for your prescriber.

In the US, Mounjaro also comes in single-dose pens and vials, which can be kept unrefrigerated up to 30 °C (86 °F) for a total of 21 days. Inject under the skin of the abdomen or thigh, or the back of the upper arm if someone else gives the shot, and rotate the site each week.

When a dose is hard to tolerate

Digestive side effects are the main reason for the four-week steps, and they rise with the dose. In the placebo-controlled type 2 diabetes trials, nausea affected 12% of people on 5 mg, 15% on 10 mg and 18% on 15 mg, against 4% on placebo (Mounjaro prescribing information). The week after each step-up is the one to watch.

The usual order of steps is to change how you eat first (smaller meals, stop when full, less fatty food), then stay on your current dose longer, then go back to the previous dose for a while. The tirzepatide dosage chart covers this in detail, with the warning signs that need a prompt call. Our Mounjaro side effects guide lists the side effects by dose.

Missed doses and changing your shot day

Situation What to do
4 days (96 hours) or less since the missed day Take it as soon as possible
More than 4 days Skip it; take the next dose on your usual day
Moving your shot day Allowed if the two doses are at least 3 days (72 hours) apart
Missed several weeks in a row No rule in the labels; ask your prescriber which dose to restart on

Never take two doses within three days of each other. For longer breaks, the tirzepatide trials restarted people at the same dose after one or two missed doses, and at 5 mg after three or more (Lilly Medical). That’s trial practice, not a label instruction.

Mounjaro in the US, the UK and the EU

The dose steps are the same everywhere: 2.5 mg to start, 2.5 mg increases, 15 mg maximum (EMA product information). What differs is the approval. In the US, Mounjaro is approved for type 2 diabetes, and the weight-management version of tirzepatide is sold as Zepbound (see the Zepbound dosage chart). In the UK and EU, Mounjaro is also authorised for weight management in adults with a BMI of 30 or more, or 27 to under 30 with at least one weight-related health problem (MHRA).

Before surgery, during pregnancy, and with the pill

  • Surgery or sedation: tell the team doing any planned operation under anaesthesia that you take Mounjaro.
  • Birth control pills: tirzepatide can make them less effective. The labels advise switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after each dose increase. Writing down the date of every step makes that easy to follow.
  • Pregnancy: talk to your prescriber before trying to conceive, or as soon as you find out you’re pregnant.

Keeping a record of each step

Six possible doses, a new pen strength at each change, and a birth-control window after every increase add up to a lot of dates. In Mingo, every shot is saved with its dose, the weight chart marks the first shot of each new dose, and side effects are rated from 0 to 10 on the same timeline. Mingo doesn’t decide when you move up a dose; it keeps the record you and your prescriber decide with. Note the date you opened each KwikPen in the shot’s notes, so you know when its 30 days are up.

Frequently asked questions

What is the starting dose of Mounjaro?

2.5 mg once a week. The labels say to stay on it for at least four weeks before any increase.

Can I start Mounjaro at 5 mg?

The labels start everyone at 2.5 mg. The slow start is there to reduce stomach side effects, which rise with the dose.

How often can the Mounjaro dose go up?

By 2.5 mg at a time, and only after at least four weeks on the current dose. Your prescriber decides whether to increase at all.

Do I have to reach 15 mg?

No. 15 mg is a ceiling, not a target. Many people stay on a lower dose that works for them and that they tolerate.

How many doses are in a Mounjaro KwikPen?

Four weekly doses of the same strength. Once opened it lasts 30 days, and any medicine left after the fourth dose shouldn't be used.

Can I count clicks to get an extra dose or a smaller dose from my KwikPen?

No. The leaflet says not to use medicine left in the pen after the four doses, and Lilly says splitting tirzepatide doses hasn't been studied and isn't recommended.

What if I miss a Mounjaro dose?

Take it within four days (96 hours) of the missed day. After that, skip it and take the next dose on your usual day.

Is Mounjaro approved for weight loss in the UK?

Yes, for adults with a BMI of 30 or more, or 27 to under 30 with a weight-related health problem. In the US, Mounjaro is for type 2 diabetes and the weight-management brand is Zepbound.

Sources

Medication facts on this page come from the official prescribing information and the studies listed here. Your prescriber sets your dose and schedule. Updated .

  1. Mounjaro prescribing information, revised 8/2026 (DailyMed)
  2. Mounjaro KwikPen package leaflet: information for the patient (UK, electronic medicines compendium)
  3. Mounjaro summary of product characteristics (European Medicines Agency)
  4. MHRA authorises Mounjaro for weight management and weight loss (November 8, 2023)
  5. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022
  6. Lilly Medical: Can a dose of tirzepatide be split into smaller doses? (reviewed August 25, 2026)
  7. Lilly Medical: Missed doses and restarting in the tirzepatide trials (reviewed January 29, 2026)

Dose charts for other GLP-1 medications